和黄医药(00013)：执行董事兼首席财务官郑泽锋担任代理首席执行官⼀职

Core Viewpoint - The company Hutchison China MediTech Limited (和黄医药) announced that its Executive Director Dr. Su Weiguo will temporarily suspend his role as Chief Executive Officer due to health reasons [1] Group 1: Management Changes - The board has appointed Mr. Zheng Zefeng, the current Executive Director and Chief Financial Officer, as the acting Chief Executive Officer effective immediately [1] - Mr. Zheng will oversee the company's daily operations and management during the transition period to ensure continuity in leadership and decision-making [1]